The added cost and limited evidence dont strongly support it
However, patients should be aware of potential adverse reactions and seek medical advice if they experience severe or persistent symptoms
April 22, 2026: Removed from Category 2 On April 15, 2026, the FDA published a 503A category revision removing 12 peptides from Category 2 effective seven calendar days later (April 22)
Most protocols recommend using BPC-157 for 48 weeks, though longer courses may be appropriate for chronic conditions under professional guidance

Key Features Blend strength: BPC-157 10 mg + TB-500 10 mg per vial (20 mg total) Pack size: 10 vials/kit (bulk supply available on request) Format: lyophilized powder for stable storage and handling in lab workflows Supplier positioning: China-based factory supply with export-ready cartons and secure packing Documentation: batch labeling and order coordination support for repeat wholesale buyers Typical Research Focuses Recovery-support and tissue-repair pathway models (non-clinical, research settings) Mobility & training-load recovery study frameworks (protocol-based, lab handling required) Stack compatibility research and stability handling for lyophilized peptide formats General peptide handling, storage, and logistics workflows for distributors Packaging & Ordering Standard inner packing: 10-vial plastic trays with bubble wrap and foam protection Outer packing: export-ready cartons with insulation and protective materials suitable for international transit Flexible order quantities starting from 1 kit for sample evaluation

In addition, dyspareunia was reported to significantly impact womens sexual relationships